Hyung-Seung Jin

8PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersTumour immunologyGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 30, 2024
Revisiting T-cell adhesion molecules as potential targets for cancer immunotherapy: CD226 and CD2.

Yunju Jo, Hye-In Sim, Bohwan Yun

|Oct 20, 2023
A CRISPR activation screen identifies MUC-21 as critical for resistance to NK and T cell-mediated cytotoxicity.

Dong-Hee Lee, Hyejin Ahn, Hye-In Sim

|Jan 23, 2023
Enhancing adoptive T-cell therapy with fucoidan-based IL-2 delivery microcapsules.

Eun Young Jeon, Da-Som Choi, Seunghyun Choi

|Feb 25, 2022
PBK/TOPK Is a Favorable Prognostic Biomarker Correlated with Antitumor Immunity in Colon Cancers.

Dong-Hee Lee, Yu-Jeong Jeong, Ju-Young Won

|Oct 23, 2021
Mucin1 and Mucin16: Therapeutic Targets for Cancer Therapy.

Dong-Hee Lee, Seunghyun Choi, Yoon Park

|Mar 06, 2021
TIGIT/CD226 Axis Regulates Anti-Tumor Immunity.

Jinah Yeo, Minkyung Ko, Dong-Hee Lee

Pageof 2

Frequent Collaborators

4 joint publications

Yoon Park

2 joint publications

Minkyung Ko

1 joint publications

Seong-Ho Kang

1 joint publications

Jeonghyun Lee